NeoGenomics, Inc. (NASDAQ:NEO) Q4 2024 Earnings Call Transcript
Operator: Welcome to the NeoGenomics Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Neogenomics Inc (NEO)
Market is closed
Sector: Services-Testing Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 116,381,000 | $98,269,207 | 2.91% | ||
| 2. | Greenhouse Funds Joe Milano | 4,701,897 | $77,487,263 | +6% | 3.23% |
| 3. | Millennium Management Israel Englander | 1,425,789 | $23,497,003 | +3441% | 0.01% |
| 4. | Royce & Associates Chuck Royce | 675,866 | $11,138,272 | +6% | 0.1% |
| 5. | 253,600 | $4,179,328 | +88% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.63 | 17,000 | Officer, Director | 72,736 | 2021-12-06 | Filing | |
| $11.60 | 26,000 | Director | 103,866 | 2018-12-21 | Filing | |
| $9.19 | 20,000 | Director | 38,782 | 2017-07-27 | Filing | |
| $6.75 | 14,800 | Director | 110,547 | 2016-03-03 | Filing | |
| $6.84 | 7,207 | Director | 117,754 | 2016-03-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.36 | 5,175 | Officer | 37,129 | 2024-11-15 | Filing | |
| $16.05 | 1,040 | Officer | 43,813 | 2024-08-15 | Filing | |
| $15.74 | 1,049 | Officer | 44,867 | 2024-05-15 | Filing | |
| $15.97 | 6,112 | Director | 50,062 | 2024-03-04 | Filing | |
| $14.96 | 2,587 | Officer | 34,866 | 2024-02-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 366,589 | $3,478,903 | 0% | |
| 2. | 2,000,000 | $1,983,946 | 1.05% | |
| 3. | 85,347 | $809,943 | 0.08% | |
| 4. | 48,883 | $463,900 | 0.01% | |
| 5. | Imc-chicago, LlcCALL | 32,100 | $304,629 | 0% |
News See All
NeoGenomics, Inc. (NASDAQ:NEO) Q3 2024 Earnings Call Transcript
Operator: Welcome to the NeoGenomics Third Quarter 2024 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode.
NeoGenomics, Inc. (NASDAQ:NEO) Q2 2024 Earnings Call Transcript
Operator: Welcome to the NeoGenomics Second Quarter 2024 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode.
20 Most Profitable Stocks of the Last 20 Years
The stock market has a long history of generating wealth for investors. While past performance doesn't guarantee future results, studying successful companies can provide valuable insights.
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript
NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03.
NeoGenomics, Inc. (NASDAQ:NEO) Q4 2023 Earnings Call Transcript
NeoGenomics, Inc. beats earnings expectations. Reported EPS is $0.03, expectations were $-0.01.
NeoGenomics, Inc. (NASDAQ:NEO) Q3 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the NeoGenomics Third Quarter 2023 Earnings Call -- Third Quarter 2023 Financial Results Conference Call and Webcast.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
NeoGenomics, Inc. (NASDAQ:NEO) Q2 2023 Earnings Call Transcript
Operator: Welcome to the NeoGenomics Second Quarter 2023 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode.
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2023 Earnings Call Transcript
Operator: Welcome to the NeoGenomics First Quarter 2023 Financial Results Conference Call and Webcast. At this time all participants are in listen only mode.
Billionaire Hedge Funds
